Impacto de la angioplastia primaria en la indicación de desfibrilador implantable en pacientes con infarto de miocardio

Moss, 1996, Improved survival with an implanted defibrillator in patients with coronary disease at high risk forventricular tachycardia, N Engl J Med, 335, 1933, 10.1056/NEJM199612263352601 Buxton, 1999, A randomized study of the prevention of sudden death in patients with coronary artery disease, N Engl J Med, 341, 1882, 10.1056/NEJM199912163412503 Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474 Bigger, 2002, Expanding indications for implantable cardiac defibrillators, N Engl J Med, 346, 931, 10.1056/NEJMe020011 Brugada, 2002, La interrupción prematura del estudio MADIT-II: ¿un gran impacto en la economía sanitaria?, Rev Esp Cardiol, 55, 87, 10.1016/S0300-8932(02)76565-2 Zijlstra, 1993, A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction, N Engl J Med, 328, 680, 10.1056/NEJM199303113281002 Gibbons, 1993, Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups, N Engl J Med, 328, 685, 10.1056/NEJM199303113281003 De Boer, 1994, Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction, Circulation, 90, 753, 10.1161/01.CIR.90.2.753 Ottervanger, 2001, Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction, Eur Heart J, 22, 726, 10.1053/euhj.2000.2316 Aguirre, 1991, Importance of myocardial infarct artery patency on the prevalence of ventricular arrhythmia and late potentials after thrombolysis in acute myocardial infarction, Am J Cardiol, 68, 1410, 10.1016/0002-9149(91)90272-M Hohnloser, 1994, Open infarct artery, late potentials, and other factors in patients after acute myocardial infarction in the thrombolytic era. A prospective trial, Circulation, 90, 1747, 10.1161/01.CIR.90.4.1747 De Chillou, 1997, Am J Cardiol, 80, 852, 10.1016/S0002-9149(97)00535-3 1999, A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction), Circulation, 100, 1016, 10.1161/01.CIR.100.9.1016 Bigger, 1984, The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction, Circulation, 69, 250, 10.1161/01.CIR.69.2.250 Mukharji, 1984, Risk factors for sudden death after acute myocardial infarction: two-year follow-up, Am J Cardiol, 54, 31, 10.1016/0002-9149(84)90299-6 Kuchar, 1987, Prediction of serious arrhythmic events after acute myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography, J Am Coll Cardiol, 9, 531, 10.1016/S0735-1097(87)80045-1 Hohnloser, 1999, Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era, J Am Coll Cardiol, 33, 1895, 10.1016/S0735-1097(99)00108-4 Andresen, 1999, Risk stratification following myocardial infarction in the thrombolytic era. A two-step strategy using noninvasive and invasive methods, J Am Coll Cardiol, 33, 131, 10.1016/S0735-1097(98)00516-6 Alzueta, 2002, Resultados preliminares del estudio MARS (MADIT and MUSTT Registry Study) [resumen], Rev Esp Cardiol, 55, 78 1993, The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction, N Engl J Med, 329, 1615, 10.1056/NEJM199311253292204 Zijlstra, 1999, Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction, N Engl J Med, 341, 1413, 10.1056/NEJM199911043411901 Maggioni, 1993, Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era GISSI-2 results, Circulation, 87, 312, 10.1161/01.CIR.87.2.312 Bigger, 1986, Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction, Am J Cardiol, 58, 1151, 10.1016/0002-9149(86)90374-7 Andresen, 1990, Importance of quantitative analysis of ventricular arrhythmias for predicting the prognosis in low-risk postmyocardial infarction patients. European Infarction Study Group, Eur Heart J, 11, 529, 10.1093/oxfordjournals.eurheartj.a059746 De Boer, 1995, Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction, Eur Heart J, 16, 1347, 10.1093/oxfordjournals.eurheartj.a060741 Pedretti, 1993, Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricular tachycardia, Am J Cardiol, 71, 1131, 10.1016/0002-9149(93)90635-P Bhandari, 1985, Frequency and significance of induced sustained ventricular tachycardia or fibrillation two weeks after acute myocardial infarction, Am J Cardiol, 56, 737, 10.1016/0002-9149(85)91125-7 Wilber, 1990, Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function, Circulation, 82, 350, 10.1161/01.CIR.82.2.350 Senges, 2002, Variability of Holter electrocardiographic findings in patients fulfilling the noninvasive MADIT criteria, PACE, 25, 183, 10.1046/j.1460-9592.2002.00183.x